Deutsches MDS-Forum - Dresden 2006: Vom Nihilismus zum Algorithmus
Pathogenese der myelodysplastischen Syndrome
-
Nilsson L, Astrand-Grundstrom I, Arvidsson I.
Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.
Blood 2000;96:2012-2021. PM:10979941
[Medline]
-
Strom SS, Gu Y, Gruschkus SK, Pierce SA, Estey EH.
Risk factors of myelodysplastic syndromes: a case-control study.
Leukemia 2005;19:1912-1918. PM:16167059
[Medline]
-
Pedersen-Bjergaard J.
Insights into leukemogenesis from therapy-related leukemia.
N Engl J Med 2005;352:1591-1594. PM:15829541
[Medline]
-
Parker JE, Mufti GJ.
The myelodysplastic syndromes: a matter of life or death.
Acta Haematol 2004;111:78-99. PM:14646347
[Medline]
-
Sloand EM, Kim S, Fuhrer M.
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Blood 2002;100:4427-4432. PM:12393649
[Medline]
-
Benesch M, Platzbecker U, Ward J, Deeg HJ, Leisenring W.
Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
Leukemia 2003;12:34-40. PM:14562111
[Medline]
-
Kochenderfer JN, Kobayashi S, Wieder ED, Su C, Molldrem JJ.
Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression.
Blood 2002;100:3639-3645. PM:12393644
[Medline]
-
Soenen-Cornu V, Tourino C, Bonnet ML.
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.
Oncogene 2005;24:2441-2448. PM:15735749
[Medline]
-
Estey EH.
Modulation of angiogenesis in patients with myelodysplastic syndrome.
Best Pract Res Clin Haematol 2004;17:623-639. PM:15494299
[Medline]
-
Nyakern M, Tazzari PL, Finelli C.
Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients.
Leukemia. 2006;20:230-238. PM:16341040
[Medline]
© 2023 ONKODIN